Search
  1. Home
  2. Africa

Drug giant joins search for AIDS vaccine

    JOHANNESBURG

    Multinational drug manufacturer GlaxoSmithKline (GSK) has joined the search for an HIV vaccine, with a promise to make an effective product affordable to developing nations.

    The company announced on Tuesday that it was setting up a joint research team with the International AIDS Vaccine Initiative in the first public-private partnership involving a major pharmaceutical company.

    Jean Stephenne, the president of GSK Biological, the company's vaccines arm, said in a statement, "The private sector has an immense amount of knowledge, resources and expertise; innovative partnerships such as this are essential to tackle the biggest global health challenges."

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join